管理肉毒毒素A剂量用于喉 dystonia 的管理
Pelin Yuksel1, Katherine D Mullen2, Kathryn A Mozzochi3
1College of Arts and Sciences, University of Pennsylvania, Philadelphia, PA.
Journal of voice : official journal of the Voice Foundation
|October 8, 2025
概括
这项关于喉 dystonia (LD) 的研究发现,不同的亚型需要不同的肉毒神经毒素 (BTX) 剂量. 个性化治疗对于性听障患者的最佳结果至关重要.
科学领域:
- 神经学 神经学
- 耳鼻喉科 耳鼻喉科 耳鼻喉科
- 语言病理学 语音病理学
背景情况:
- 喉 dystonia (LD),或性失声症,显著影响生活质量.
- 目前的治疗包括注射肉毒神经毒素 (BTX),但疗效各不相同.
- 研究往往忽略了与添加体LD相比,绑架型和混合型LD亚型.
研究的目的:
- 分析一组多样化的LD患者的表现和治疗.
- 为了在LD亚型中比较肉毒神经毒素 (BTX) 治疗参数.
- 调查影响BTX在性失声症管理中的有效性因素.
主要方法:
- 对31名成年性失声症 (SD) 患者的回顾性图表审查.
- 对肉毒神经毒素A (BTX) 单位,喘息持续时间和注射间隔的分析.
- 数据按LD亚型分层划分 (吸附器与吸附器/混合).
主要成果:
- 平均BTX剂量为10.2个单位 (吸收器) 和15.1个单位 (吸收器/混合).
- 注射间隔平均为174天.
- 注射后呼吸困难持续了21天 (吸附器) 和27天 (吸附器/混合器).
结论:
- 一些LD患者的高BTX剂量表明亚型特定的治疗需求.
- 剂量变化表明,在某些个体中,可能对低剂量BTX没有反应.
- 个性化治疗策略对于有效的LD管理至关重要.
关键词:
肉毒毒素是一种毒素.化工消化剂化工消化剂喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia 喉 dystonia喉注射是指用喉注射的方式.喉运动障碍 喉运动障碍spasmodic dysphonia 性失声症 性失声症 性失声症 性失声症更多相关视频
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K
Skeletal Muscle Relaxants: Therapeutic Uses
891
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
891
Depolarizing Blockers: Pharmocokinetics
566
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
566
Skeletal Muscle Relaxants: Adverse Effects
773
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
773
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
894
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
894


